Table 4.
Fitted Bayesian log-normal survival model for Non-relapse related survival (NRRS) in 215 patients, including 67 patients treated with BuCy2 and 148 with treated Bu-Flu.
| Variable | Mean | SD | Posterior 95% Credible Interval | Probability of a Beneficial Effect | |
|---|---|---|---|---|---|
|
| |||||
| 2.50% | 97.50% | ||||
| Intercept | 5.131 | 1.343 | 2.671 | 7.944 | - |
| Cyto = bad (vs. Other) | 0.996 | 0.681 | −0.294 | 2.371 | 0.934 |
| Disease status = CR (vs. not in CR) | −0.092 | 0.712 | −1.488 | 1.313 | 0.448 |
| Allo type = Sib/Other Rel (vs. Unrelated) | 1.396 | 0.602 | 0.277 | 2.684 | 0.994 |
| Age | −0.055 | 0.025 | −0.109 | −0.009 | 0.009 |
| PB Blast = 0 (vs. > 0) | 0.922 | 0.709 | −0.466 | 2.334 | 0.909 |
| PB PLT | 0.002 | 0.002 | −0.002 | 0.007 | 0.755 |
| Confounded Bu-Flu (vs. BuCy2) Effect | 1.880 | 0.651 | 0.664 | 3.258 | 0.999 |
| R | 0.166 | 0.049 | 0.087 | 0.277 | - |
Abbreviations: Cyto, cytogenetics; PB, peripheral blood, Allo, allogeneic; Sib, sibling; Rel, related; PLT, platelet; CR, complete remission)